F. De Baets (Gent, Belgium), G. A. Rossi (Genoa, Italy)
Pivot trial A multicentre randomised controlled equivalence trial comparing oral amoxycillin and intravenous penicillin for community acquired pneumonia in children
M. Atkinson, M. Lakhanpaul, A. Smyth, H. Vyas, V. Weston, J. Sithole, V. Owen, K. Halliday, H. Sammons, L. Walton, J. Crane, N. Guntupalli, A. Qureshi, A. Morjaria, T. Stephenson (Nottingham, United Kingdom)
|  |
Microbiological study of community acquired pneumonia versus nosocomial pneumonia in pediatric age group
M. Y. El Saify, M. A. Shaheen, L. A. Koleif (Cairo, Egypt)
| |
Community acquired pneumonia (CAP) in children over 3 years old - etiology, antibiotic sensitiveness and treatment
L. S. Nikolova, L. Stojanovska, O. Stefanovska (Skopje, Fyrom)
| |
Risk factors and seriousness of pneumonia in the under 5’s
A. Goya, G. F. Ferrari (Botucatu, Brazil)
| |
Pneumonia associated with transient hyperphosphatasaemia
S. Banac, V. Ahel, V. Ro¿manic, N. Cace (Rijeka, Croatia)
| |
Ventilatory sequels after pneumonia in the first three years of life: a ten years follow-up
M. L. Maneva, E. A. Canevska (Skopje, Macedonia)
| |
Pleural empyema in acute bacterial pneumonia in children
D. K. Gidaris, E. Chatzioannides, M. Banduraki, S. Petridou, M. Stoyannidou, C. Doumpali, D. Tsonoglou, R. Valeri (Thessaloniki, Greece)
| |
Pleural adenosine deaminase determination combined with differential cell counts for early discrimination of exudative pleural effusion in children
S. A. Shin, Y. S. Choi, J. Y. Chang, J. W. Oh, H. B. Lee (Seoul, South Korea)
| |
The value of pleural fluid PCR method for detection of S. aureus, S. pneumoniae and H. influenzae in pediatric parapneumonic effusions
E. G. Utine, U. Özcelik, E. G. Yalcin, D. Menemenlioglu, A. Pinar, B. Sener, D. Dogru, A. T. Aslan, N. Kiper, D. Gur (Ankara, Turkey)
| |
Biochemical aspects of pleural fluid during the course of pleural infection in pediatric parapneumonic effusions and the role of IL-8, TNF-a and nitric oxide in inflammation
E. G. Utine, U. Özcelik, E. G. Yalcin, D. Dogru, A. T. Aslan, N. Kiper (Ankara, Turkey)
| |
Diagnostic approach of atypical pneumonia with routine laboratory examinations
A. Hatzimichail, A. Pantazi, V. Gourtsa, A. Tsalkidis, A. Esebidou (Alexandroupolis, Komotini, Greece)
| |
Azithromycin in treatment of atypical pneumonia in children
M. M. Micic-Stanojevic, S. V. Smiljanic, Z. M. Zivkovic, S. D. Radic, D. P. Velickovic (Belgrade, Serbia & Montenegro)
| |
Nonspecific interstitial pneumonitis as a cause of dyspnea
D. Can, C. Dizdarer, T. Mese, M. E. Çakmakli, H. Alper, P. W. Bishop (Izmir, Turkey; Manchester, United Kingdom)
| |
Laboratory findings, physical and clinical features of mycoplasma pneumoniae infections. Analysis of 21 cases
S. Altinoz, R. Tanac, E. Demir, F. Gulen, D. Zeyrek, M. Ozcetin (Izmir, Turkey)
| |
Early lower airway infection: risk factors for asthma at age of 14-16 years
E. Piippo-Savolainen, M. Hyvärinen, K. Korhonen, M. Korppi (Kuopio, Finland)
| |
Early RSV infection is not a significant risk factor for asthma at age of 14-16 years
M. Hyvärinen, E. Piippo-Savolainen, K. Korhonen, M. Korppi (Kuopio, Finland)
| |
Lung disease associated with the human immunodeficiency virus in Brazilian children
A. D. Toro, M. N. DaSilva, A. M. Altemanni, V. A. Zanardi, J. R. Menezes, M. M. S. Vilela (Campinas, Brazil)
| |
Non-specific interstitial pneumonia of the pediatric age and recombinant interferon gamma-1b
D. Rigante, S. Valente, L. Avallone, G. Pagliari, A. Stabile (Rome, Italy)
| |
Chloroquine treatment of interstitial lung diseases in children
C. Mahraoui, J. De Blic, P. Scheinmann (Rabat, Morocco; Paris, France)
| |